• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:张柏祥,朱翔,安昱畅,邓山,陈佳滢,郑燕芳,黄鸣清.LncRNA CAHM抑制高糖诱导的人肾系膜细胞增殖和纤维化[J].中国现代应用药学,2026,43(18):160-169.
Zhang Bo Xiang,ZHU Xiang,AN Yu-Chang,Deng Shan,CHEN Jia-Ying,ZHENG Yan-Fang,HUANG Ming-Qing.LncRNA CAHM Inhibits Hyperglucose-induced Proliferation and Fibrosis of Human Renal Membrane Cells[J].Chin J Mod Appl Pharm(中国现代应用药学),2026,43(18):160-169.
【打印本页】   【HTML】   【下载PDF全文】   【查看/发表评论】  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 11次   下载 13次 本文二维码信息
码上扫一扫!
LncRNA CAHM抑制高糖诱导的人肾系膜细胞增殖和纤维化
张柏祥1, 朱翔2, 安昱畅1, 邓山1, 陈佳滢1, 郑燕芳1, 黄鸣清1
1.福建中医药大学药学院;2.福建中医药大学针灸学院
摘要:
摘要:目的 探讨长链非编码RNA CAHM(LncRNA CAHM)对高糖诱导的人肾系膜细胞([] HRMC)增殖和纤维化的影响及机制。方法 将HRMC细胞分为对照组、高糖(HG)组、oe-CAHM组、si-CAHM-1组、si-CAHM-2组、oe-Krüppel样因子4(KLF4)组、Anisomycin组、si-CAHM+oe-KLF4组、oe-CAHM+Anisomycin组和oe-KLF4+Anisomycin组。采用噻唑蓝(MTT)、5-乙基-20-脱氧尿苷(EdU)、流式细胞术和蛋白质免疫印迹分析HRMC细胞的增殖和纤维化情况。结果 与HG组相比,CAHM和KLF4过表达均抑制了HRMC细胞的增殖和纤维化(P < 0.05),但二者的抑制作用可被c-Jun氨基末端激酶(JNK)激动剂-Anisomycin逆转(P < 0.05);si-CAHM促进细胞增殖和纤维化,但si-CAHM+oe-KLF4可减弱si-CAHM的促增殖和纤维化作用(P < 0.05)。结论 CAHM可通过抑制JNK通路,进而抑制高糖诱导的HRMC细胞增殖和纤维化,提示CAHM可能是糖尿病肾病(DN)的潜在治疗靶点。
关键词:  糖尿病肾病  人肾系膜细胞  CAHM  KLF4  JNK通路
DOI:
分类号:
基金项目:
LncRNA CAHM Inhibits Hyperglucose-induced Proliferation and Fibrosis of Human Renal Membrane Cells
Zhang Bo Xiang,ZHU Xiang,AN Yu-Chang,Deng Shan,CHEN Jia-Ying,ZHENG Yan-Fang,HUANG Ming-Qing
College of Pharmacy, Fujian University of Traditional Chinese Medicine
Abstract:
ABSTRACT: OBJECTIVE In order to investigate the effect and mechanism of long non-coding RNA CAHM (LncRNA CAHM) on hyperglucose-induced proliferation and fibrosis of human renal mesangial cells (HRMCs).METHODS HRMC cells were divided into control group, high glucose (HG) group, oe-CAHM group, si-CAHM-1 group, si-CAHM-2 group, oe-Krüppel-like factor 4 (KLF4) group, Anisomycin group, si-CAHM+oe-KLF4 group, oe-CAHM+Anisomycin group and oe-KLF4+Anisomycin group. The proliferation and fibrosis of HRMC cells were analyzed by thiazole blue (MTT), 5-ethyl-20-deoxyuridine (EdU), flow cytometry and western blotting. RESULTS The results showed that the overexpression of CAHM and KLF4 inhibited the proliferation and fibrosis of HRMC cells compared with the HG group (P < 0.05), but the inhibitory effect of CAHM could be reversed by the c-Jun N-terminal kinase (JNK) agonist-Anisomycin (P < 0.05). si-CAHM promoted cell proliferation and fibrosis, but si-CAHM+oe-KLF4 attenuated the proliferation and fibrosis effects of si-CAHM (P < 0.05). CONCLUSION These results indicated that CAHM could inhibit hyperglycemia-induced HRMC cell proliferation and fibrosis by inhibiting the JNK pathway, suggesting that CAHM may be a potential therapeutic target for diabetic nephropathy (DN)
Key words:  Diabetic nephropathy  Human renal membrane cell  CAHM  KLF4  JNK
扫一扫关注本刊微信